Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alize Pharma SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10851
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrelin for the treatment of metabolic and cardiovascular disorders including type 2 diabetes and Prader-Willi syndrome. Alize Pharma owns pending and granted patents that protect the UAG analogs and therapeutic applications. The company partners with academic institutions in the Netherlands and Italy. Alize Pharma is headquartered in Lyon, France.

Alize Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alize Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Alize Pharma Raises USD1.9 Million in Venture Financing 10
Alize Pharma Raises USD6.4 Million in Series A Financing 11
Alize Pharma Raises US$4 Million In Venture Financing 12
Licensing Agreements 13
Alize Pharma Enters into Licensing Agreement with New Paradigm Therapeutics 13
EUSA Pharma Enters Into Licensing Agreement With Alize Pharma For ASPAREC 14
Acquisition 15
Jazz Pharma Acquires Alize Pharma 15
Alize Pharma SAS – Key Competitors 16
Alize Pharma SAS – Key Employees 17
Alize Pharma SAS – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Alize Pharma SAS, Pharmaceuticals & Healthcare, Key Facts 2
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alize Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alize Pharma SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alize Pharma Raises USD1.9 Million in Venture Financing 10
Alize Pharma Raises USD6.4 Million in Series A Financing 11
Alize Pharma Raises US$4 Million In Venture Financing 12
Alize Pharma Enters into Licensing Agreement with New Paradigm Therapeutics 13
EUSA Pharma Enters Into Licensing Agreement With Alize Pharma For ASPAREC 14
Jazz Pharma Acquires Alize Pharma 15
Alize Pharma SAS, Key Competitors 16
Alize Pharma SAS, Key Employees 17

List of Figures
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alize Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medibank Private Limited (MPL):企業の財務・戦略的SWOT分析
    Medibank Private Limited (MPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rousselot S.A.S. :企業の戦略・SWOT・財務分析
    SummaryRousselot S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Universal Forest Products, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Universal Forest Products, Inc. …
  • LINN Energy, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LINN Energy, LLC Mergers and Ac …
  • Knights of Columbus:企業概要及び戦略的SWOT分析
    Knights of Columbus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • ITOCHU Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ITOCHU Corporation Mergers and …
  • Strides Arcolab Limited (STAR):企業概要、財務及び戦略的SWOT分析
    Summary Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. The company specializes in manufacturing IP-led niche generics and bio-pharmaceuticals. Strides Arcolab serves areas such as pharma generics, and branded generics. Its pharma generics focuses on developing and manufacturi …
  • KenolKobil Limited (KOCL):企業の財務及び戦略的SWOT分析
    Summary KenolKobil Limited (KenolKobil) is an oil marketing company that operates, markets and sells petroleum products. The company offers petroleum products such as aviation fuels, motor fuels, and liquefied petroleum gas, lubricants, industrial oils and other specialist oils, among others. KenolK …
  • Metso Corporation (MEO1V):企業財務及び戦略的SWOT分析
    Metso Corporation (MEO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dilafor AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Dilafor AB (Dilafor) is a drug development company that develops pharmaceutical products for obstetric indications. The company offers tafoxiparin, a proprietary heparan sulfate mimetic, which is used as an adjuvant therapy to promote cervical ripening and myometrial contractility. Its tafox …
  • CAMAC Energy Inc. (CAK):企業概要、財務及び戦略的SWOT分析
    Summary CAMAC Energy Inc. (CAMAC) is an energy exploration company. The company explores, develops, produces and distributes oil and gas. It has offshore and onshore projects of production, development and exploration assets in West Africa and Asia. CAMAC concentrates on cash flow and high-return gl …
  • Valeant International (Barbados) SRL (formerly Biovail Laboratories International SRL):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Valeant International (Barbados …
  • GfK SE:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GfK SE Mergers and Acquisitions …
  • National Beef Packing Company LLC.(消費財分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "National Beef Packing Company LLC.: Consumer Packaged Goods - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, bus …
  • Bain & Company, Inc.:戦略・SWOT・企業財務分析
    Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Seven Energy International Limited:企業のM&A・提携動向(石油・ガス分野)
    Summary Seven Energy International Limited (Seven Energy) is an oil and gas company that offers exploration services. The company explores, develops, produces and distributes oil and gas properties. It provides both upstream and midstream services. Seven Energy’s upstream assets include licence inte …
  • Franklin Covey Co. (FC):企業財務及び戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AK Transneft (TRNFP):石油・ガス:M&Aディール及び事業提携情報
    Summary AK Transneft (Transneft) is a midstream oil and gas pipeline company that specializes in the transportation of crude oil and refined petroleum products. The company transports oil and oil products through trunk pipelines in the Russian Federation and outside. It carries out preventive mainte …
  • Telekom Austria AG:企業のM&A・提携・投資分析
    Telekom Austria AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Telekom Austria AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆